Oral contraceptives combined with interferon β in multiple sclerosis
نویسندگان
چکیده
منابع مشابه
Oral contraceptives combined with interferon β in multiple sclerosis
OBJECTIVE To test the effect of oral contraceptives (OCs) in combination with interferon β (IFN-β) on disease activity in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS One hundred fifty women with RRMS were randomized in a 1:1:1 ratio to receive IFN-β-1a subcutaneously (SC) only (group 1), IFN-β-1a SC plus ethinylstradiol 20 μg and desogestrel 150 μg (group 2), or IFN-β...
متن کاملInterferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis
Background: Statins, widely used cholesterol-lowering agents, have also been demonstrated to have anti-inflammatory and immunomdulatory effects. Objective: To evaluate the effects of atorvastatin in combination with Interferon-β in the treatment of multiple sclerosis (MS) in a randomized controlled clinical trial. Methods: Multiple sclerosis patients were randomized independently, in a double b...
متن کاملOral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility
BACKGROUND The incidence of multiple sclerosis (MS) is rising in women. OBJECTIVE To determine whether the use of combined oral contraceptives (COCs) are associated with MS risk and whether this varies by progestin content. METHODS We conducted a nested case-control study of females ages 14-48 years with incident MS or clinically isolated syndrome (CIS) 2008-2011 from the membership of Kais...
متن کاملNeuroprotective Effects of Interferon-β in Multiple Sclerosis
Multiple sclerosis (MS) is considered an immune-mediated, demyelinating, and degenerative disease of the central nervous system (CNS). The immune-mediated pathogenesis is supported by the significant infiltration of leukocytes into the CNS parenchyma and by the finding of a substantial similarity between active MS plaques and lesions in the CNS of animals with experimental autoimmune encephalom...
متن کاملOral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
BACKGROUND Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on imaging in a phase 2 study involving patients with multiple sclerosis. METHODS In this 12-month, double-blind, double-dummy study, we randomly assigned 1292 patients with relapsing-remitting multiple sclerosis who had a rece...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology - Neuroimmunology Neuroinflammation
سال: 2015
ISSN: 2332-7812
DOI: 10.1212/nxi.0000000000000120